RARE - Ultragenyx Pharmaceutical Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.87B
Enterprise Value 32.3B
Trailing P/E N/A
Forward P/E 1-8.57
PEG Ratio (5 yr expected) 1-0.81
Price/Sales (ttm)76.11
Price/Book (mrq)4.32
Enterprise Value/Revenue 361.15
Enterprise Value/EBITDA 6-6.53

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018


Profit Margin 0.00%
Operating Margin (ttm)-987.75%

Management Effectiveness

Return on Assets (ttm)-38.73%
Return on Equity (ttm)-37.25%

Income Statement

Revenue (ttm)37.65M
Revenue Per Share (ttm)0.79
Quarterly Revenue Growth (yoy)5,840.90%
Gross Profit (ttm)-229.03M
EBITDA -352.76M
Net Income Avi to Common (ttm)-191.52M
Diluted EPS (ttm)-4.00
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)503.1M
Total Cash Per Share (mrq)9.95
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)8.51
Book Value Per Share (mrq)13.11

Cash Flow Statement

Operating Cash Flow (ttm)-316.54M
Levered Free Cash Flow (ttm)-180.65M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.88
52-Week Change 315.11%
S&P500 52-Week Change 31.08%
52 Week High 390.98
52 Week Low 337.44
50-Day Moving Average 349.51
200-Day Moving Average 361.77

Share Statistics

Avg Vol (3 month) 3516.6k
Avg Vol (10 day) 3515.02k
Shares Outstanding 550.58M
Float 47.26M
% Held by Insiders 16.44%
% Held by Institutions 1103.29%
Shares Short (Jan 31, 2019) 45.48M
Short Ratio (Jan 31, 2019) 49.35
Short % of Float (Jan 31, 2019) 415.38%
Short % of Shares Outstanding (Jan 31, 2019) 410.84%
Shares Short (prior month Dec 31, 2018) 44.98M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 23/1
Last Split Date 3Jan 17, 2014